Free Trial
→ NNVC FDA = New Momentum Wave! (From Equiscreen) (Ad)tc pixel Free PHG Stock Alerts

Koninklijke Philips (PHG) Financials

Koninklijke Philips logo
$25.62 -0.01 (-0.02%)
As of 02:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Koninklijke Philips

Annual Income Statements for Koninklijke Philips

This table shows Koninklijke Philips' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 708 1,523 2,503 1,248 1,311 1,644 3,756 -1,720 -512 -722 1,050
Consolidated Net Income / (Loss)		 693 1,569 2,246 1,256 1,316 1,460 3,761 -1,717 -512 -722 1,053
Net Income / (Loss) Continuing Operations		 174 874 1,235 1,499 1,111 1,220 693 -1,731 -502 -869 1,057
Total Pre-Tax Income 		357 1,088 1,654 1,720 1,401 1,479 576 -1,852 -582 127 1,387
Total Operating Income		 618 1,540 1,641 1,967 1,360 1,570 555 -1,654 363 863 1,629
Total Gross Profit		 7,836 8,352 9,827 9,790 8,865 9,553 8,113 7,696 8,239 8,046 9,457
Total Revenue		 18,260 18,328 21,358 20,740 19,243 21,150 19,417 19,071 20,099 18,654 20,930
Operating Revenue		 18,260 18,328 21,358 20,740 19,243 21,150 19,417 19,071 20,099 18,654 20,930
Total Cost of Revenue		 10,424 9,977 11,532 10,951 10,380 11,597 11,304 11,375 11,968 10,736 11,473
Operating Cost of Revenue		 10,424 9,977 11,532 10,951 10,380 11,597 11,304 11,375 11,968 10,736 11,473
Total Operating Expenses		 7,218 6,830 8,186 7,823 7,505 7,983 7,558 9,350 7,768 7,054 7,828
Selling, General & Admin Expense		 5,488 5,050 5,976 5,872 5,287 5,722 5,497 5,661 5,677 5,246 5,833
Research & Development Expense		 1,697 1,756 2,119 2,013 2,009 2,226 2,044 2,237 2,091 1,808 1,995
Total Other Income / (Expense), net		 -261 -436 13 -241 39 84 27 -195 -944 -736 -231
Interest Expense		 492 533 316 302 261 247 213 276 416 401 406
Interest & Investment Income		 102 68 151 58 128 193 169 62 70 109 133
Other Income / (Expense), net		 129 29 178 2.29 173 138 71 19 -597 -444 42
Income Tax Expense		 184 214 419 221 290 259 -117 -121 -81 997 331
Net Income / (Loss) Discontinued Operations		 520 694 1,013 244 205 239 3,068 14 -11 147 -4.69
Net Income / (Loss) Attributable to Noncontrolling Interest		 -15 -45 -257 -8.01 5.61 -9.77 -4.53 -3.21 - - -1.17
Basic Earnings per Share		 $0.68 $1.58 $2.14 $1.16 $1.27 $1.31 $3.52 ($1.81) - - $1.10
Weighted Average Basic Shares Outstanding		 - - 926.19M 914.18M 890.97M 905.13M 870.18M 881.48M 906.40M 925.01M 962.92M
Diluted Earnings per Share		 $0.68 $1.56 $2.10 $1.14 $1.25 $1.29 $3.50 ($1.81) - - $1.09
Weighted Average Diluted Shares Outstanding		 - - 926.19M 914.18M 890.97M 905.13M 870.18M 881.48M 906.40M 925.01M 962.92M
Basic & Diluted Earnings per Share		 - - - - - - $3.52 ($1.81) - - $1.10
Weighted Average Basic & Diluted Shares Outstanding		 - - 926.19M 914.18M 890.97M 905.13M 870.18M 881.48M 906.40M 925.01M 962.92M

Quarterly Income Statements for Koninklijke Philips

No quarterly income statements for Koninklijke Philips are available.

Annual Cash Flow Statements for Koninklijke Philips

This table details how cash moves in and out of Koninklijke Philips' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 3,984 2,864 -5,694 5,459 15,045 3,152 -10,082 -694 1,145 -1,178 -704
Net Cash From Operating Activities		 608 775 -1,930 6,691 12,244 1,863 -7,437 235 1,331 -747 -155
Net Cash From Continuing Operating Activities		 608 775 -1,930 6,691 12,244 1,863 -7,437 -1,241 1,331 -747 -155
Net Income / (Loss) Continuing Operations		 693 1,569 2,246 1,256 1,316 1,460 3,761 -1,717 -512 -722 1,053
Consolidated Net Income / (Loss)		 693 1,569 2,246 1,256 1,316 1,460 3,761 -1,717 -512 -722 1,053
Non-Cash Adjustments To Reconcile Net Income		 -1,063 -1,949 -5,195 5,135 10,530 -70 -11,446 971 1,447 579 -1,321
Changes in Operating Assets and Liabilities, net		 -78 129 -213 300 397 473 248 -733 396 -603 114
Net Cash From Investing Activities		 1,027 -178 -3,856 -1,980 59 -2,022 -4,622 -1,360 -887 -879 -1,109
Net Cash From Continuing Investing Activities		 1,027 -178 -3,856 -1,980 59 -2,022 -4,622 -1,360 -887 -879 -1,109
Purchase of Property, Plant & Equipment		 - -401 -1,327 - - - -1,274 -750 -994 -1,014 -1,090
Acquisitions		 1,215 207 -2,816 - - -387 -3,506 -762 -81 -8.28 -3.52
Sale of Property, Plant & Equipment		 -265 16 210 -1,341 -387 -1,639 37 19 100 13 11
Divestitures		 77 0.00 77 -639 447 4.89 121 133 88 130 -26
Net Cash From Financing Activities		 1,882 -594 -710 -279 2,335 953 -832 520 -206 -89 110
Net Cash From Continuing Financing Activities		 1,882 -594 -710 -279 2,335 953 -832 520 -206 -89 110
Repayment of Debt		 99 -1,073 -1,586 - - -364 -370 -1,524 -802 -821 -743
Payment of Dividends		 324 349 -464 -462 511 -3.66 -548 -447 -5.53 -3.11 -387
Issuance of Debt		 1,459 129 1,339 183 1,825 1,321 86 2,692 602 735 1,240
Effect of Exchange Rate Changes		 87 -18 -221 0.00 2.24 -67 74 - -87 47 -163
Other Net Changes in Cash		 380 2,878 1,023 1,028 404 2,425 2,736 -90 994 491 613
Cash Interest Received		 48 44 48 40 28 16 19 16 59 86 97

Quarterly Cash Flow Statements for Koninklijke Philips

No quarterly cash flow statements for Koninklijke Philips are available.

Annual Balance Sheets for Koninklijke Philips

This table presents Koninklijke Philips' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 33,948 30,410 29,779 30,319 33,854 35,042 32,830 32,529 29,993 31,621
Total Current Assets		 14,807 9,851 9,652 10,615 13,715 10,797 9,988 10,996 10,374 11,656
Cash & Equivalents		 2,455 2,329 1,932 1,599 3,941 2,607 1,254 2,067 2,485 3,279
Short-Term Investments		 106 - - 1.12 0.00 - - 50 71 95
Accounts Receivable		 5,604 4,696 4,618 5,111 5,077 4,286 4,402 4,129 3,801 4,143
Inventories, net		 5,862 2,827 3,060 - - 3,905 4,332 3,862 3,310 3,368
Current Deferred & Refundable Income Taxes		 162 - - - - - - 243 97 70
Other Current Assets		 106 - 41 - - - - - 609 621
Plant, Property, & Equipment, net		 2,267 15,619 -11,664 0.00 0.00 1,925 1,733 0.00 0.00 0.00
Total Noncurrent Assets		 16,874 2,081 13,475 16,241 16,780 -6,923 11,593 18,785 17,083 17,362
Long-Term Investments		 200 -1,822 279 1.12 7.33 -1,006 -599 421 266 174
Goodwill		 9,361 13,277 9,732 9,712 9,790 16,170 14,725 10,925 10,747 10,880
Intangible Assets		 3,737 - - 3,890 3,661 - - 3,529 3,087 3,015
Noncurrent Deferred & Refundable Income Taxes		 2,902 1,920 2,092 2,093 2,223 2,508 2,620 2,906 1,983 2,081
Other Noncurrent Operating Assets		 674 -13,079 1,087 346 817 -24,929 -5,533 1,004 1,000 1,212
Total Liabilities & Shareholders' Equity		 33,948 30,410 15,573 30,319 33,854 35,042 23,315 32,529 29,993 31,621
Total Liabilities		 16,604 15,058 15,328 12,788 14,770 15,837 16,121 19,187 17,527 18,724
Total Current Liabilities		 11,018 7,600 5,858 7,831 9,449 6,543 6,698 9,167 8,432 8,813
Short-Term Debt		 1,667 807 1,595 - - 573 996 723 544 1,351
Accounts Payable		 2,996 2,511 2,636 2,344 2,589 2,119 2,105 2,121 1,894 2,262
Accrued Expenses		 - 2,786 - - - 2,019 1,739 2,087 1,687 1,897
Current Deferred & Payable Income Tax Liabilities		 154 100 135 112 70 145 43 92 73 204
Other Current Liabilities		 3,009 1,397 1,491 75 94 1,688 1,814 4,122 4,233 3,088
Total Noncurrent Liabilities		 8,778 7,457 9,471 8,319 9,867 9,294 9,423 10,020 9,095 9,912
Long-Term Debt		 4,230 4,858 3,922 5,543 6,969 7,326 7,777 7,782 7,363 8,138
Noncurrent Deferred & Payable Income Tax Liabilities		 69 -91 213 369 428 506 325 510 84 109
Other Noncurrent Operating Liabilities		 4,478 2,681 5,322 2,408 2,469 1,461 1,320 1,727 1,650 1,667
Total Equity & Noncontrolling Interests		 1,150 14,668 245 14,169 222 6,346 7,194 13,342 12,466 12,898
Total Preferred & Common Equity		 27,351 14,640 212 201 222 6,305 7,158 13,305 12,427 12,859
Total Common Equity		 196 14,640 212 14,137 14,500 6,305 7,158 1,175 0.00 0.00
Noncontrolling Interest		 954 29 33 31 38 41 36 37 38 38

Quarterly Balance Sheets for Koninklijke Philips

No quarterly balance sheets for Koninklijke Philips are available.

Annual Metrics And Ratios for Koninklijke Philips

This table displays calculated financial ratios and metrics derived from Koninklijke Philips' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.37% 16.53% -2.90% -7.21% 9.91% -8.19% -1.78% 5.39% -7.19% 12.20%
EBITDA Growth		 0.00% 43.95% 17.47% -35.42% -22.17% 11.40% -63.35% -87.35% -397.63% 332.39% 298.65%
EBIT Growth		 0.00% 109.97% 15.87% 8.30% -22.17% 11.40% -63.35% -361.17% 85.59% 332.39% 298.65%
NOPAT Growth		 0.00% 311.67% -1.03% 39.98% -37.08% 20.02% -48.51% -273.62% 84.82% -3,752.69% 121.04%
Net Income Growth		 0.00% 126.27% 43.21% -44.11% 4.85% 10.89% 157.63% -145.65% 70.17% -41.07% 245.71%
EPS Growth		 0.00% 129.41% 34.76% -45.77% 9.65% 3.20% 171.32% -151.66% 70.02% -43.23% 0.00%
Operating Cash Flow Growth		 0.00% 27.42% -348.98% 446.60% 83.00% -84.78% -499.21% 103.16% 465.42% -156.16% 79.27%
Free Cash Flow Firm Growth		 0.00% 0.00% 129.48% 224.15% -184.86% 107.28% 1,721.60% -197.68% 95.61% -490.46% 101.78%
Invested Capital Growth		 0.00% 0.00% -21.72% -104.02% 2,589.54% 0.99% -123.57% 498.82% 4.67% -9.65% 7.67%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 42.91% 45.57% 46.01% 47.20% 46.07% 45.17% 41.78% 40.35% 40.99% 43.13% 45.18%
EBITDA Margin		 9.88% 14.17% 14.28% 9.50% 7.97% 8.07% 3.22% 0.42% -1.17% 2.94% 7.98%
Operating Margin		 3.39% 8.40% 7.68% 9.49% 7.07% 7.42% 2.86% -8.67% -1.25% 5.32% 7.78%
EBIT Margin		 4.09% 8.56% 8.52% 9.50% 7.97% 8.07% 3.22% -8.57% -1.17% 2.94% 7.98%
Profit (Net Income) Margin		 3.80% 8.56% 10.52% 6.05% 6.84% 6.90% 19.37% -9.00% -2.55% -3.87% 5.03%
Tax Burden Percent		 193.92% 144.20% 135.80% 72.99% 93.99% 98.68% 652.85% 92.72% 88.02% -567.48% 75.89%
Interest Burden Percent		 47.82% 69.30% 90.95% 87.33% 91.36% 86.62% 92.04% 113.29% 246.95% 23.25% 83.01%
Effective Tax Rate		 51.37% 19.63% 25.35% 12.84% 20.67% 17.51% -20.24% 0.00% 0.00% 782.93% 23.86%
Return on Invested Capital (ROIC)		 0.00% 12.09% 6.71% 22.29% 14.02% 8.03% 10.77% -20.29% -1.13% -44.64% 7.96%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 15.51% 16.58% -171.44% 62.28% 9.88% 117.21% 32.24% -7.45% 222.15% 1.50%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 260.74% 21.69% -5.45% 4.25% 12.26% 103.75% -5.07% -3.86% 39.04% 0.34%
Return on Equity (ROE)		 0.00% 272.83% 28.40% 16.84% 18.27% 20.29% 114.52% -25.36% -4.99% -5.60% 8.30%
Cash Return on Invested Capital (CROIC)		 0.00% -187.91% 31.08% 0.00% -97.29% 7.04% 0.00% -132.68% -5.69% -34.50% 0.57%
Operating Return on Assets (OROA)		 0.00% 4.62% 5.65% 6.55% 5.10% 5.32% 1.82% -4.82% -0.72% 1.75% 5.42%
Return on Assets (ROA)		 0.00% 4.62% 6.98% 4.17% 4.38% 4.55% 10.92% -5.06% -1.57% -2.31% 3.42%
Return on Common Equity (ROCE)		 0.00% 46.43% 26.64% 16.77% 18.18% 40.37% 362.75% -25.22% -2.02% -0.73% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 5.73% 15.34% 592.97% 655.31% 656.59% 59.65% -23.99% -3.85% -5.81% 0.00%
Net Operating Profit after Tax (NOPAT)		 301 1,238 1,225 1,715 1,079 1,295 667 -1,158 -176 -6,772 1,240
NOPAT Margin		 1.65% 6.75% 5.74% 8.27% 5.61% 6.12% 3.43% -6.07% -0.87% -36.30% 5.93%
Net Nonoperating Expense Percent (NNEP)		 0.00% -3.42% -9.87% 193.72% -48.27% -1.85% -106.44% -52.53% 6.33% -266.79% 6.45%
Return On Investment Capital (ROIC_SIMPLE)		 - 17.56% 6.02% 29.76% 5.47% 18.01% 4.68% -7.25% -0.80% -33.24% 5.54%
Cost of Revenue to Revenue		 57.09% 54.44% 53.99% 52.80% 53.94% 54.83% 58.22% 59.65% 59.01% 56.87% 54.82%
SG&A Expenses to Revenue		 30.05% 27.55% 27.98% 28.32% 27.47% 27.05% 28.31% 29.69% 28.25% 28.12% 27.87%
R&D to Revenue		 9.29% 9.58% 9.92% 9.71% 10.44% 10.52% 10.53% 11.73% 10.40% 9.69% 9.53%
Operating Expenses to Revenue		 39.53% 37.26% 38.33% 37.72% 39.00% 37.75% 38.93% 49.03% 42.24% 37.82% 37.40%
Earnings before Interest and Taxes (EBIT)		 748 1,570 1,819 1,970 1,533 1,708 626 -1,635 -236 548 1,671
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,804 2,596 3,050 1,970 1,533 1,708 626 79 -236 548 1,671
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 136.25 2.86 3.14 5.08 1.82 17.51 10.49 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 75.66 43.39 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 1.39 2.10 2.15 1.65 0.68 1.02 1.23 1.20
Price to Earnings (P/E)		 0.00 0.00 0.00 23.13 30.90 27.69 8.53 0.00 0.00 0.00 23.85
Dividend Yield		 4.29% 3.48% 2.74% 3.02% 2.17% 0.00% 2.92% 6.43% 0.00% 0.00% 3.75%
Earnings Yield		 0.00% 0.00% 0.00% 4.32% 3.24% 3.61% 11.73% 0.00% 0.00% 0.00% 4.19%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 2.77 3.00 0.00 1.39 2.07 2.43 1.92
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 1.55 2.31 2.30 1.98 1.11 1.64 1.87 1.48
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 16.34 29.01 28.45 61.30 267.78 0.00 63.85 18.57
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 16.34 29.01 28.45 61.30 0.00 0.00 63.85 18.57
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 18.77 41.22 37.52 57.54 0.00 0.00 0.00 25.02
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 4.81 3.63 26.08 0.00 90.07 24.81 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 1.75 0.00 42.79 1.85 0.00 0.00 0.00 351.60
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 5.13 0.39 22.53 0.39 31.35 1.24 1.22 0.64 0.63 0.74
Long-Term Debt to Equity		 0.00 3.68 0.33 16.01 0.39 31.35 1.15 1.08 0.58 0.59 0.63
Financial Leverage		 0.00 16.81 1.31 0.03 0.07 1.24 0.89 -0.16 0.52 0.18 0.23
Leverage Ratio		 0.00 29.52 4.07 4.04 4.17 4.46 10.49 5.01 3.18 2.42 2.43
Compound Leverage Factor		 0.00 20.46 3.70 3.52 3.81 3.86 9.65 5.68 7.86 0.56 2.02
Debt to Total Capital		 0.00% 83.68% 27.86% 95.75% 28.12% 96.91% 55.45% 54.94% 38.93% 38.81% 42.39%
Short-Term Debt to Total Capital		 0.00% 23.66% 3.97% 27.69% 0.00% 0.00% 4.02% 6.24% 3.31% 2.67% 6.03%
Long-Term Debt to Total Capital		 0.00% 60.02% 23.89% 68.06% 28.12% 96.91% 51.43% 48.71% 35.62% 36.14% 36.35%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 29.50% 33.81% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 13.54% 0.14% 0.58% 0.16% 0.53% 0.29% 0.23% 0.17% 0.19% 0.17%
Common Equity to Total Capital		 0.00% 2.78% 72.00% 3.67% 71.72% 201.63% 44.26% 44.83% 5.38% 10.74% 0.00%
Debt to EBITDA		 0.00 2.27 1.86 2.80 3.62 4.08 12.62 110.82 -36.10 14.44 5.68
Net Debt to EBITDA		 0.00 1.21 1.69 1.68 2.57 1.77 10.06 102.55 -25.32 9.29 3.55
Long-Term Debt to EBITDA		 0.00 1.63 1.59 1.99 3.62 4.08 11.71 98.24 -33.03 13.45 4.87
Debt to NOPAT		 0.00 4.76 4.62 3.22 5.14 5.38 11.85 -7.58 -48.39 -1.17 7.65
Net Debt to NOPAT		 0.00 2.53 4.21 1.93 3.65 2.33 9.45 -7.01 -33.95 -0.75 4.79
Long-Term Debt to NOPAT		 0.00 3.42 3.97 2.29 5.14 5.38 10.99 -6.72 -44.27 -1.09 6.56
Altman Z-Score		 0.00 0.00 0.00 2.20 2.81 2.79 1.97 1.02 1.30 1.55 1.75
Noncontrolling Interest Sharing Ratio		 0.00% 82.98% 6.21% 0.42% 0.45% -99.00% -216.76% 0.57% 59.42% 86.97% 100.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.34 1.30 1.65 1.36 1.45 1.65 1.49 1.20 1.23 1.32
Quick Ratio		 0.00 0.74 0.92 1.12 0.86 0.95 1.05 0.84 0.68 0.75 0.85
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -19,243 5,674 18,391 -15,607 1,136 20,686 -20,206 -886 -5,234 88
Operating Cash Flow to CapEx		 229.51% 201.37% -172.80% 498.81% 3,162.32% 113.64% -601.19% 32.21% 148.70% -74.66% -14.35%
Free Cash Flow to Firm to Interest Expense		 0.00 -36.08 17.96 60.87 -59.69 4.60 97.22 -73.21 -2.13 -13.07 0.22
Operating Cash Flow to Interest Expense		 1.24 1.45 -6.11 22.14 46.82 7.55 -34.95 0.85 3.20 -1.87 -0.38
Operating Cash Flow Less CapEx to Interest Expense		 0.70 0.73 -9.65 17.70 45.34 0.91 -40.77 -1.79 1.05 -4.36 -3.04
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.54 0.66 0.69 0.64 0.66 0.56 0.56 0.62 0.60 0.68
Accounts Receivable Turnover		 0.00 3.27 4.15 4.45 3.96 4.15 4.15 4.39 4.71 4.70 5.27
Inventory Turnover		 0.00 1.70 2.65 3.72 0.00 0.00 0.00 2.76 2.89 2.96 3.44
Fixed Asset Turnover		 0.00 8.08 2.39 0.00 0.00 0.00 0.00 10.43 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 3.33 4.19 4.26 4.17 4.70 4.80 5.39 5.61 5.28 5.52
Days Sales Outstanding (DSO)		 0.00 111.60 88.01 81.96 92.27 87.91 88.00 83.14 77.47 77.59 69.27
Days Inventory Outstanding (DIO)		 0.00 214.44 137.50 98.11 0.00 0.00 0.00 132.14 126.08 123.39 106.23
Days Payable Outstanding (DPO)		 0.00 109.61 87.15 85.77 87.56 77.63 76.00 67.77 65.03 69.07 66.10
Cash Conversion Cycle (CCC)		 0.00 216.44 138.36 94.30 4.70 10.28 12.01 147.51 138.52 131.91 109.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 20,480 16,032 -644 16,042 16,201 -3,819 15,230 15,940 14,402 16,165
Invested Capital Turnover		 0.00 1.79 1.17 2.70 2.50 1.31 3.14 3.34 1.29 1.23 1.34
Increase / (Decrease) in Invested Capital		 0.00 20,480 -4,449 -16,676 16,686 159 -20,020 19,048 711 -1,538 1,152
Enterprise Value (EV)		 0.00 0.00 0.00 32,189 44,474 48,589 38,370 21,199 33,014 34,960 31,028
Market Capitalization		 0.00 0.00 0.00 28,850 40,501 45,530 32,031 13,044 20,565 22,950 25,049
Book Value per Share		 $0.00 $0.00 $15.81 $0.23 $15.46 $16.27 $7.25 $8.12 $1.33 $2.41 $0.00
Tangible Book Value per Share		 $0.00 $0.00 $1.47 ($10.28) $0.59 $1.18 ($11.34) ($8.58) ($15.06) ($12.85) ($15.02)
Total Capital		 0.00 7,047 20,333 5,763 19,711 7,192 14,245 15,968 21,847 20,373 22,386
Total Debt		 0.00 5,898 5,665 5,518 5,543 6,969 7,899 8,773 8,506 7,907 9,489
Total Long-Term Debt		 0.00 4,230 4,858 3,922 5,543 6,969 7,326 7,777 7,782 7,363 8,138
Net Debt		 0.00 3,136 5,158 3,306 3,941 3,021 6,298 8,119 5,967 5,084 5,941
Capital Expenditures (CapEx)		 265 385 1,117 1,341 387 1,639 1,237 731 895 1,001 1,080
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 2,895 729 3,458 1,184 325 2,221 3,032 435 -70 820
Debt-free Net Working Capital (DFNWC)		 0.00 5,457 3,058 5,389 2,784 4,266 4,827 4,286 2,552 2,486 4,194
Net Working Capital (NWC)		 0.00 3,789 2,251 3,794 2,784 4,266 4,254 3,290 1,829 1,942 2,844
Net Nonoperating Expense (NNE)		 -393 -331 -1,021 459 -237 -165 -3,094 559 336 -6,050 188
Net Nonoperating Obligations (NNO)		 0.00 19,331 1,363 -889 1,873 15,979 -10,165 8,035 2,598 1,937 3,267
Total Depreciation and Amortization (D&A)		 1,056 1,027 1,231 0.00 0.00 0.00 0.00 1,714 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 15.80% 3.41% 16.67% 6.15% 1.54% 11.44% 15.90% 2.16% -0.38% 3.92%
Debt-free Net Working Capital to Revenue		 0.00% 29.77% 14.32% 25.99% 14.47% 20.17% 24.86% 22.47% 12.70% 13.33% 20.04%
Net Working Capital to Revenue		 0.00% 20.68% 10.54% 18.29% 14.47% 20.17% 21.91% 17.25% 9.10% 10.41% 13.59%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $1.78 $1.18 $1.45 $0.00 $0.00 $0.00 ($0.51) ($0.78) $1.10
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 926.19M 914.18M 890.97M 0.00 0.00 0.00 906.40M 925.01M 962.92M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $1.75 $1.16 $1.44 $0.00 $0.00 $0.00 ($0.51) ($0.78) $1.09
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 926.19M 914.18M 890.97M 0.00 0.00 0.00 906.40M 925.01M 962.92M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($0.78) $1.10
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 926.19M 914.18M 890.97M 0.00 0.00 0.00 906.40M 925.01M 962.92M
Normalized Net Operating Profit after Tax (NOPAT)		 433 1,238 1,225 1,715 1,079 1,295 400 -142 -170 694 1,240
Normalized NOPAT Margin		 2.37% 6.75% 5.74% 8.27% 5.61% 6.12% 2.06% -0.74% -0.84% 3.72% 5.93%
Pre Tax Income Margin		 1.96% 5.94% 7.74% 8.29% 7.28% 6.99% 2.97% -9.71% -2.90% 0.68% 6.63%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.52 2.94 5.76 6.52 5.86 6.92 2.94 -5.92 -0.57 1.37 4.12
NOPAT to Interest Expense		 0.61 2.32 3.88 5.68 4.13 5.25 3.13 -4.19 -0.42 -16.91 3.05
EBIT Less CapEx to Interest Expense		 0.98 2.22 2.22 2.08 4.38 0.28 -2.87 -8.57 -2.72 -1.13 1.46
NOPAT Less CapEx to Interest Expense		 0.07 1.60 0.34 1.24 2.65 -1.40 -2.68 -6.84 -2.57 -19.40 0.40
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -46.71% -22.27% 20.64% 36.83% -38.79% 0.25% 14.57% -26.04% -1.08% -0.43% 36.79%
Augmented Payout Ratio		 -46.71% -22.27% 20.64% 36.83% -38.79% 0.25% 14.57% -37.69% -1.08% -0.43% 36.79%

Quarterly Metrics And Ratios for Koninklijke Philips

No quarterly metrics and ratios for Koninklijke Philips are available.


Financials Breakdown Chart

Koninklijke Philips Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Koninklijke Philips' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Koninklijke Philips' net income appears to be on a downward trend, with a most recent value of $1.05 billion in 2025, rising from $693.22 million in 2015. The previous period was -$722.50 million in 2024. View Koninklijke Philips' forecast to see where analysts expect Koninklijke Philips to go next.

Koninklijke Philips' total operating income in 2025 was $1.63 billion, based on the following breakdown:
  • Total Gross Profit: $9.46 billion
  • Total Operating Expenses: $7.83 billion

Over the last 10 years, Koninklijke Philips' total revenue changed from $18.26 billion in 2015 to $20.93 billion in 2025, a change of 14.6%.

Koninklijke Philips' total liabilities were at $18.72 billion at the end of 2025, a 6.8% increase from 2024, and a 12.8% increase since 2016.

In the past 9 years, Koninklijke Philips' cash and equivalents has ranged from $1.25 billion in 2022 to $3.94 billion in 2020, and is currently $3.28 billion as of their latest financial filing in 2025.

Over the last 10 years, Koninklijke Philips' book value per share changed from 0.00 in 2015 to 0.00 in 2025, a change of 0.0%.


Related Companies

Financial statements for NYSE:PHG last updated on 2/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
J.P. Morgan is betting on this coin
For the first time in history, autonomous AI programs can hold, send, and receive funds — completely without h...
Crypto 101 Media | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel